Literature DB >> 810952

The immunological significance of cellular infiltrates in chronic rejection of human kidney transplants.

E Schlüter, K Lennert, A Bohle.   

Abstract

Fifteen transplanted human kidneys with clinical and histological signs of chronic rejection were examined microscopically for cellular infiltration. Three normal kidneys were used as a reference. All infiltrating cells were classified and counted. The average number of cells per 10 microscopic fields was called the relative density of cellular infiltrates. Differences in the densities of different cell classes and changes in the cellular infiltration of the grafts were regarded as cellular expressions of the immune response. Summarizing our results, we conclude that: 1) the chronic immunological rejection of transplanted human kidneys is essentially caused by immunocompetent cells; 2) plasma cells develop in the graft itself; 3) the immunocompetent cell population tends to be purely and simply made up of plasma cells; 4) therefore, the true "effector cell" among the immunocompetent cells may be the plasma cell--at least in the chronic rejection of transplanted human kidneys. Cleaved lymphocytes were the most frequent of the infiltrating cells found in the transplants. However, their role is not yet clear.

Entities:  

Mesh:

Year:  1975        PMID: 810952     DOI: 10.1007/BF00432522

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  15 in total

1.  Morphology and pathogenesis of glomerulopathy in cadaver kidney allografts treated with antilymphocyte globulin.

Authors:  H U Zollinger; J Moppert; G Thiel; H P Rohr
Journal:  Curr Top Pathol       Date:  1973

2.  Germinal centres and the origin of the B-cell system. I. Germinal centres in the rabbit appendix.

Authors:  P Nieuwenhuis; C E van Nouhuijs; J H Eggens; F J Keuning
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

3.  Germinal centres and the origin of the B-cell system. II. Germinal centres in the rabbit spleen and popliteal lymph nodes.

Authors:  P Nieuwenhuis; F J Keuning
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

4.  The ultrastructure of an abnormal cell in Sézary's syndrome.

Authors:  M A Lutzner; H W Jordan
Journal:  Blood       Date:  1968-06       Impact factor: 22.113

5.  [Study of plasmocytopoiesis. II. Probable scheme of the means of formation of plasmocytes elaborated from the results of the numeration of their mitoses].

Authors:  G Sainte-Marie
Journal:  Nouv Rev Fr Hematol       Date:  1966 Jul-Aug

6.  Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant.

Authors:  M A Lutzner; I Emerit; R Durepaire; G Flandrin; C Grupper; M Prunieras
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

7.  [Membrane asectsin immunology].

Authors:  H Fischer; E Rüde; D Sellin
Journal:  Naturwissenschaften       Date:  1970-11

Review 8.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

9.  The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants.

Authors:  N C Pedersen; B Morris
Journal:  J Exp Med       Date:  1970-05-01       Impact factor: 14.307

10.  The role of humoral antibody in the rejection of primary renal allografts in sheep.

Authors:  N C Pedersen; B Morris
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  2 in total

1.  Plasma cells and immunoglobulin-synthesis in oral precancer and cancer. Correlation with dysplasia, cancer differentiation, radio- and chemotherapy.

Authors:  T Löning; A Burkhardt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979

2.  Lymphocyte monitoring as a predictor of renal allograft rejection.

Authors:  S B Leapman; D M Strong; S Alpert; N J Feduska; K W Sell
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.